| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/04/2002 | WO2001085793A3 G protein-coupled receptors |
| 07/04/2002 | WO2001083563A3 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001068855A3 Gtp-binding protein gamma-12 subunit |
| 07/04/2002 | WO2001059089A3 Improved galactosylation of recombinant glycoproteins |
| 07/04/2002 | WO2001055364A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055328A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055325A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055322A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055321A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055318A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055311A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055308A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001032673A9 Sequences encoding human neoplastic marker |
| 07/04/2002 | WO2000071729A9 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/04/2002 | WO2000068396A9 Bacillus circulans xylanase mutants |
| 07/04/2002 | US20020087003 Such as terfenadine carboxylic acid metabolite, 4-(4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl) -alpha- alpha-dimethylphenylacetic acid; side effect reduction of terfenadine arrythmia |
| 07/04/2002 | US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 07/04/2002 | US20020086981 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086978 Specific binding agents |
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
| 07/04/2002 | US20020086849 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/04/2002 | US20020086845 Rat PTTG polypeptide and method for producing it |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity |
| 07/04/2002 | US20020086826 Antibodies against ligand for receptor activator of NF-kB |
| 07/04/2002 | US20020086813 Mutants of streptococcal toxin a and methods of use |
| 07/04/2002 | US20020086424 Biodetectors targeted to specific ligands |
| 07/04/2002 | US20020086420 Novel antiangiogenic peptides |
| 07/04/2002 | US20020086415 Corn steep for use in the generation of human and animal feeds |
| 07/04/2002 | US20020086408 Ubiquitin-like conjugating protein |
| 07/04/2002 | US20020086406 Enzymatic polypeptide for use in the treatment, diagnosis and prevention of cancer, autoimmune and nervous system disorders |
| 07/04/2002 | US20020086404 Nucleotide sequences coding for the luxR gene |
| 07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
| 07/04/2002 | US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides |
| 07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/04/2002 | US20020086380 Enzymatic polypeptide for use in animal feeds and in generating chemical intermediates for vitamin A |
| 07/04/2002 | US20020086379 Human membrane-spanning proteins |
| 07/04/2002 | US20020086378 Generation of acetic acid; obtain acetogenic bacteria, remove carbon dioxide from fermentation broth, incubate broth with solvent, continuously distill acetic acid from solvent |
| 07/04/2002 | US20020086374 Polynucleotide coding transport protein for use in generation of preferential amino acids |
| 07/04/2002 | US20020086371 Microorganism for use in the generation of lysine; for use in the generation of enzymatic polypeptides for animal feeds and nutrients |
| 07/04/2002 | US20020086370 Method of producing l-lysine |
| 07/04/2002 | US20020086367 Novel secreted proteins |
| 07/04/2002 | US20020086366 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 07/04/2002 | US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke |
| 07/04/2002 | US20020086359 Polypeptide for use in controlling signal transduction |
| 07/04/2002 | US20020086358 Enzyme isolated from a Bifidobacterium |
| 07/04/2002 | US20020086357 32591, a novel human GTPase activating molecule and uses therefor |
| 07/04/2002 | US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy |
| 07/04/2002 | US20020086355 Nucleotide sequences coding enzymatic polypeptide for use in cosmetics, pharmacology and food processing |
| 07/04/2002 | US20020086352 Methods for expressing endostatin protein |
| 07/04/2002 | US20020086350 Microbial swollenin protein, dna sequences encoding such swollenins and method of producing such swollenins |
| 07/04/2002 | US20020086332 Method of reducing bacterial proliferation |
| 07/04/2002 | US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences |
| 07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086305 Human c-Maf compositions and methods of use thereof |
| 07/04/2002 | US20020086304 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086279 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 07/04/2002 | US20020086278 Nutrient broth; for use in the propagation and visualization of preferential bacteria |
| 07/04/2002 | US20020086032 Administering immunogenic dose of attenuated bacteria comprising altered DNA adenine methylase (Dam) activity relative to a wild-type bacteria for generating immune response and produce antibodies |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086018 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI |
| 07/04/2002 | US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 07/04/2002 | US20020084369 Continuous process for irradiating of polytetrafluoroethylene (ptfe) |
| 07/04/2002 | US20020084219 Method and apparatus for neutralizing alkaline wastewater without using mineral acids |
| 07/04/2002 | DE10149447A1 Composition for waste water treatment comprises a polymer flocculant or precipitant and a macrobiotic mixed culture |
| 07/04/2002 | DE10063314A1 Neue für das ilvE-Gen kodierende Nukleotidsequenzen New coding for the ilvE gene nucleotide sequences |
| 07/04/2002 | DE10037759A1 Screeningverfahren Screening method |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2432927A1 Antibacterial treatments |
| 07/04/2002 | CA2432715A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | CA2432380A1 Sugar beet genes involved in stress tolerance |
| 07/04/2002 | CA2432168A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | CA2432079A1 Process for producing coenzyme q10 |
| 07/04/2002 | CA2431478A1 Synovial cell protein |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/03/2002 | EP1219711A2 Lawsonia intracellularis vaccine |
| 07/03/2002 | EP1219710A1 Novel polypeptides and genes encoding the same |
| 07/03/2002 | EP1219707A2 Process, apparatus and reagents for isolating cellular components |
| 07/03/2002 | EP1219704A2 High production method of prenyl alcohol by microorganisms |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219635A2 Chlamydia pneumoniae antigenes |
| 07/03/2002 | EP1219301A1 Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
| 07/03/2002 | EP1218540A2 Transposon mediated differential hybridisation |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218530A2 Novel enzymes which dehydrate glycerol |
| 07/03/2002 | EP1218520A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218519A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218516A2 Method for preparing steroids modified by yeast fermentation |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218505A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
| 07/03/2002 | EP1218502A2 Nicotinic acetylcholine receptor : alpha10 subunit |
| 07/03/2002 | EP1218499A2 RESCUE OF MUMPS VIRUS FROM cDNA |
| 07/03/2002 | EP1218498A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |